BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18218239)

  • 1. [Insulin sensitivity and pancreatic beta cell function changes during the transformation from normal to impaired glucose tolerance].
    Li J; Yan L; Chen LH; Li Y; Li F; Liu SL; Qi YQ; Cheng H
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):842-5. PubMed ID: 18218239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.
    DeFronzo RA; Banerji MA; Bray GA; Buchanan TA; Clement S; Henry RR; Kitabchi AE; Mudaliar S; Musi N; Ratner R; Reaven P; Schwenke DC; Stentz FD; Tripathy D;
    Diabetologia; 2010 Mar; 53(3):435-45. PubMed ID: 20012012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
    Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
    Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.
    Faerch K; Vaag A; Holst JJ; Hansen T; Jørgensen T; Borch-Johnsen K
    Diabetes Care; 2009 Mar; 32(3):439-44. PubMed ID: 19056613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.
    Hong J; Zhang YF; Gu WQ; Zhang YW; Su YX; Chi ZN; Wang WQ; Li XY; Ning G
    Endocrine; 2008; 34(1-3):75-80. PubMed ID: 18979203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].
    Xiao J; Tian H; Li CL; Zhong WW; Sun BR; Li YP; Fang FS; Han XF; Liu YQ; Cheng XL
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):299-303. PubMed ID: 22781951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.
    Gastaldelli A; Ferrannini E; Miyazaki Y; Matsuda M; DeFronzo RA;
    Diabetologia; 2004 Jan; 47(1):31-9. PubMed ID: 14666364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inside out the Ragbag of Glucose Intolerance in Obese Adolescents.
    Brufani C; Tura A; Bedogni G; Luciano R; Sbrignadello S; Fintini D; Cappa M; Weiss R; Manco M
    Horm Res Paediatr; 2017; 87(5):287-294. PubMed ID: 28391281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deterioration of insulin release rate response to glucose during oral glucose tolerance test is associated with an increased risk of incident diabetes in normal glucose tolerance subjects.
    Li Y; He S; Sun Y; Li G; Xu Q; Wang C; Jia W
    IUBMB Life; 2017 Sep; 69(9):756-766. PubMed ID: 28762247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of impaired glucose tolerance: follow-up at Joslin Clinic.
    Warram JH; Sigal RJ; Martin BC; Krolewski AS; Soeldner JS
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S40-5. PubMed ID: 8894480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.